Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]

Authors Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S

Received 14 October 2014

Accepted for publication 14 October 2014

Published 28 October 2014 Volume 2014:10 Pages 913—914

DOI https://doi.org/10.2147/TCRM.S75813

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S. Ther Clin Risk Manag. 2014;10:603–614.

The TIMI abbreviation definition of “thrombosis in myocardial infarction” is incorrect for Table 2 on page 606 and Table 3 on page 607. It should read “thrombolysis in myocardial infarction”.

Read the original article

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Clinical and economic studies of eptifibatide in coronary stenting

Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S

Therapeutics and Clinical Risk Management 2014, 10:603-614

Published Date: 2 August 2014